With RR, decreased protein expression of these genes would be expected to reduce myocardial fibrosis and other ECM deposition that is increased with β1-GSN signaling in TG1 (4) and TG2 (5) LVs and was also present at baseline in the investigated patient population (3). The gene discussed is GSN; the disease is Myocardial fibrosis.